Efficacy and safety of lamotrigine in patients with trigeminal neuralgia: a comparison with carbamazepine
Keywords:Lamotrigine, Carbamazepine, Trigeminal neuralgia pain
Background: Antiepileptic drugs are increasingly used in the treatment of pain syndromes. This study evaluates efficacy and safety of lamotrigine in comparison with carbamazepine (CBZ) in trigeminal neuralgia (TN) patients.
Methods: A total of 50 previously and newly diagnosed patients of TN were administered with lamotrigine (LTG) in comparison to CBZ. The final titration in dose for LTG was 400 mg/day and 1200 mg/day for CBZ. Clinical assessment (pain relief) was done before and after 15, 30, and 60 days of drug administration by visual analog scale and verbal rating scale. Side effects were recorded during study in both groups.
Results: Of 25 patients in Group I who received CBZ, 16 patients (64%) experienced complete pain relief, while in Group II (LTG), 21 patients experienced complete pain relief. LTG was generally well tolerated except one patient was withdrawn due to skin rashes. CBZ was associated with mild hematological and central nervous system side effects.
Conclusion: LTG is as effective and safe treatment for the management of TN as compared to CBZ.
Katusic S, Beard CM, Bergstralh E, Kurland LT. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol. 1990;27(1):89-95.
Zakrzewska JM. Diagnosis and differential diagnosis of trigeminal neuralgia. Clin J Pain. 2002;18(1):14-21.
Cruccu G, Gronseth G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. AAN –FFNS guidelines on trigeminal neuralgia management. Eur J Neural. 2008;15(10):1013-28.
Brunton LL, Chabner BA, Knollman BC. Pharmacotherapy of the epilepsies. In: Goodman and Gilman’s the Pharmacological Basis of Therapeutic. 12th Edition, Chapter. 21. New York, Toronto; Mc Graw Hill; 2011: 583-608.
Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (lamictal) in refractory trigeminal neuralgia: Results from a double-blind placebo controlled crossover trial. Pain. 1997;73(2):223-30.
Chole R, Patil R, Dgwakar SS, Bhowate RR. Drug treatment of trigeminal neuralgia a systemic review of the literature. J Oral Maxillofac Surg. 2007;65(1):40-5.
Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 1991;44(3):293-9.
Macdonald RL, Greenfield LJ. Mechanism of action of new antiepileptic drug. Curr Opin Neurol. 1997;10:121-8.
Steiner TJ, Dellaportas CI, Findley LJ, Gross M, Gibberd FB, Perkin GD, et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: A double-blind comparison with phenytoin. Epilepsia. 1999;40(5):601-7.
Kaminow L, Schimschock JR, Hammer AE, Vuong A. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy. Epilepsy Behav. 2003;4(6):659-66.
Oregon Health Science University. Facial pain questionnaire. Available at: http://www.neurosurgery. Ohsu.edu/tgn.php. Accessed 12 Dec 2010.
Gift AG. Visual analogue scales: Measurement of subjective phenomena. Nurs Res. 1989;38(5):286-8.
Williamson A, Hoggart B. Pain: A review of three commonly used pain rating scales. J Clin Nurs. 2005;14(7):798-804.
Xie X, Lancaster B, Peakman T, Garthwaite J. Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones. Pflugers Arch. 1995;430(3):437-46.
Fitton A, Goa KL, Lamotrigine. Drug. 1995;50(40):691-713.
Reiser L, Pettengill CA. The use of anticonvulsants in orofacial pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;191(1):2-7.
Vinik AI, Tuchman M, Safirstein B, Corder C, Kirby L, Wilks K, et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: Results of two randomized, double-blind, placebo-controlled studies. Pain. 2007;128(1-2):169-79.
Wiffen PJ, Rees J. Lamotrigine for actue and chronic pain. Cochrane Database Syst Rev. 2007;(2):CD 006044.